These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 14826944)

  • 21. The effect of caffeine on the blood pressure of cardiac and kidney patients.
    IZSO Z
    Orv Hetil; 1952 Jun; 93(26):752-4. PubMed ID: 13003335
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the renal clearance in the patients with cardiac and renal diseases with special reference to the relations between renal clearance and blood pressure].
    OGATA S
    Fukushima Igaku Zasshi; 1961 Oct; 11():1043-61. PubMed ID: 14481234
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.
    Swaminathan S; High WA; Ranville J; Horn TD; Hiatt K; Thomas M; Brown HH; Shah SV
    Kidney Int; 2008 Jun; 73(12):1413-8. PubMed ID: 18401336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet.
    KEMPNER W
    Ann Intern Med; 1949 Nov; 31(5):821-56, illust. PubMed ID: 15393016
    [No Abstract]   [Full Text] [Related]  

  • 25. The vitamin D system: a crosstalk between the heart and kidney.
    Cozzolino M; Ketteler M; Zehnder D
    Eur J Heart Fail; 2010 Oct; 12(10):1031-41. PubMed ID: 20605845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiorenal syndrome.
    Ronco C; Chionh CY; Haapio M; Anavekar NS; House A; Bellomo R
    Blood Purif; 2009; 27(1):114-26. PubMed ID: 19169027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphate: a stealthier killer than previously thought?
    Gonzalez-Parra E; Tuñón J; Egido J; Ortiz A
    Cardiovasc Pathol; 2012; 21(5):372-81. PubMed ID: 22425627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salt consumption and cardiovascular, renal, and hypertensive diseases: clinical and mechanistic aspects.
    Susic D; Frohlich ED
    Curr Opin Lipidol; 2012 Feb; 23(1):11-6. PubMed ID: 22123673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lethally progressing disease of the vessels of the kidney and the heart as complications in antisyphilitic therapy.
    JARLØV NV
    Acta Med Scand; 1949 Jun; 133(6):377-81. PubMed ID: 18141710
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of exercise on the renal bolld flow and filtration rate of normal and cardiac subjects; preliminary report.
    MERRILL AJ; CARGILL WH
    Proc Am Fed Clin Res; 1947; 3():34. PubMed ID: 18933144
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dynamics of blood vessel reactions as shown by plethysmography in heart diseases during radon hydrotherapy].
    DANENKOV IaI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1955; (3):3-8. PubMed ID: 13257047
    [No Abstract]   [Full Text] [Related]  

  • 32. The role and control of renal dysfunction in congestive heart failure.
    LEITER L
    N Y State J Med; 1948 Aug; 48(16):1803-6. PubMed ID: 18876021
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic kidney disease: effects on the cardiovascular system.
    Schiffrin EL; Lipman ML; Mann JF
    Circulation; 2007 Jul; 116(1):85-97. PubMed ID: 17606856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anemia in kidney diseases as a cardiovascular risk factor].
    Myśliwiec M; Zalewski G
    Przegl Lek; 2005; 62 Suppl 2():19-21. PubMed ID: 16623112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radical dietary treatment of hypertensive and arteriosclerotic vascular disease, heart and kidney disease, and vascular retinopathy.
    KEMPNER W
    GP; 1954 Mar; 9(3):71-92. PubMed ID: 13128034
    [No Abstract]   [Full Text] [Related]  

  • 36. [Renal cardiopathy or cor renale].
    MONASTERIO G
    Prog Med (Napoli); 1955 Jul; 11(14):417-26. PubMed ID: 13254888
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomised intervention study to assess the prevalence of subclinical vascular disease and hidden kidney disease and its impact on morbidity and mortality: The ILERVAS project.
    Betriu À; Farràs C; Abajo M; Martinez-Alonso M; Arroyo D; Barbé F; Buti M; Lecube A; Portero M; Purroy F; Torres G; Valdivielso JM; Fernández E
    Nefrologia; 2016; 36(4):389-96. PubMed ID: 27044887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.
    Poortvliet R; de Craen A; Gussekloo J; de Ruijter W
    Age Ageing; 2015 Sep; 44(5):841-7. PubMed ID: 26209786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research on renal tubular mass in hypertension and heart diseases].
    HIMBERT J; LENEGRE J
    J Urol Medicale Chir; 1956 Mar; 62(3):146-64. PubMed ID: 13346818
    [No Abstract]   [Full Text] [Related]  

  • 40. Drugs and the Kidneys: Clinical Pharmacology Perspectives.
    Vincent J
    Clin Pharmacol Ther; 2017 Sep; 102(3):368-372. PubMed ID: 28782823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.